Last reviewed · How we verify

NCT03541018

Different Treatments With the TRV Reposition Chair

Completed NA Last updated 29 July 2022
What this trial tests

NA trial testing Type of repositional maneuvre in Benign Paroxysmal Positional Vertigo in 100 participants. Completed in 1 January 2022.

Timeline
1 January 2018
Primary endpoint
1 December 2021
1 January 2022

Quick facts

Lead sponsorAalborg University Hospital
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment100
Start date1 January 2018
Primary completion1 December 2021
Estimated completion1 January 2022
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Aalborg University Hospital

Who can join

18 and older, any sex, with Benign Paroxysmal Positional Vertigo. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate which treatment option (reposition maneuver) with the TRV chair that is the most effective in patients diagnosed with benign paroxysmal positional vertigo (BPPV). Subtypes of BPPV will be examined after randomization to specific treatments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Benign Paroxysmal Positional Vertigo

Currently open trials in the same condition.

Other Aalborg University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03541018.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing